Vienna Declaration (drug policy)

Last updated

The Vienna Declaration (2010) was a call for evidence-based drug policies prompted by the failure of traditional drug policies in the HIV/AIDS pandemic.

Contents

Background

The Vienna Declaration was published in July 2010 prior to the XVIII International AIDS Conference, 2010 (AIDS 2010), [1] which took place on 18–23 July 2010. [2] The conference's focus was on human rights and its quintessential role in HIV/AIDS pandemic response. [3] The Vienna Declaration was the second formal declaration in an International AIDS Conference, the first was the Durban Declaration (2000). [1] The declaration was a communal effort by: the International AIDS Society, the International Centre for Science in Drug Policy (ICSDP), and the British Columbia Centre for Excellence in HIV/AIDS. [4] The Lancet published a copy of the Vienna Declaration text along with a series of articles and comments on HIV in people who use drugs within the same period of the declaration's release. [5] It initially had its own website (www.viennadelcaration.com) which contained: statements of support, an overview of the declaration. The website has since been taken down. By the end of the conference, the Vienna Declaration had 12,725 signatures. [1] [6]

In 2010, human rights and universal access in HIV/AIDS responses were the central focus of HIV/AIDS organizations, governments, stakeholders, etc. [3] The 1988 IV International AIDS Conference marked a shift — biomedical to social, political, economic, and human rights — in the perspective from which HIV/AIDS was viewed. [1] Target 6.B of the Millennium Development Goals set 2010 as the target year for universal access to HIV/AIDS treatment, prevention, and services. [7] The Declaration of Commitment (2001) set 2010 as a target year to meet specified population goals. [8] The Political Declaration of Commitment (2006) emphasized the importance of government participation, in addition to all other organizations, agencies and individual, in creating an environment conducive to HIV/AIDS prevention, intervention, and services by ensuring human rights and individual freedoms. [9]

The Great Recession reduced the amount of public funding given towards HIV/AIDS organizations and causes. [3]

Vienna Declaration

The declaration listed the harms of the traditional, punitive drug policies and offered drug-policy recommendations in the harm reduction category as alternatives.

Harms of traditional drug policies

Financial

The "War on Drugs" drug control policy was a failure, money spent was not only wasted but served to actually cause more damage to society. [10] [11] [12]

A macroeconomic black drug market – valued at $320 billion a year, or the 21st economy in the world – emerged because of traditional drug policies. [10] [13]

Social and human rights

The criminalization of drug users has led to the highest global incarceration rates, in which racial disparities at the disproportionately-targeting hands of drug-law enforcement are evident. The incarceration rates change entire community social structures, and in turn functions. [10] [14]

Severe human rights violations have been committed at the expense of punitive drug control methods. Individuals have been forced to trade portions of their civil rights in exchange for security. [10] [13]

Health and HIV

The criminalization of drug users — and their subsequent institutionalization — increases the amount, severity and frequency of HIV epidemics within that cohort. The epidemics are exacerbated because institutions have little to no HIV prevention services. [10]

Related Research Articles

<span class="mw-page-title-main">Joint United Nations Programme on HIV/AIDS</span> United Nations organization

The Joint United Nations Programme on HIV and AIDS is the main advocate for accelerated, comprehensive and coordinated global action on the HIV/AIDS pandemic.

<span class="mw-page-title-main">Peter Piot</span> Belgian microbiologist (born 1949)

Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.

<span class="mw-page-title-main">Millennium Development Goals</span> Eight international development goals for the year 2015 by the United Nations

In the United Nations, the Millennium Development Goals (MDGs) were eight international development goals for the year 2015 created following the Millennium Summit, following the adoption of the United Nations Millennium Declaration. These were based on the OECD DAC International Development Goals agreed by Development Ministers in the "Shaping the 21st Century Strategy". The Sustainable Development Goals (SDGs) succeeded the MDGs in 2016.

<span class="mw-page-title-main">United Nations Office on Drugs and Crime</span> Intergovernmental organization

The United Nations Office on Drugs and Crime is a United Nations office that was established in 1997 as the Office for Drug Control and Crime Prevention by combining the United Nations International Drug Control Program (UNDCP) and the Crime Prevention and Criminal Justice Division in the United Nations Office at Vienna, adopting the current name in 2002.

<span class="mw-page-title-main">Global health</span> Health of populations in a global context

Global health is the health of populations in a worldwide context; it has been defined as "the area of study, research, and practice that places a priority on improving health and achieving equity in health for all people worldwide". Problems that transcend national borders or have a global political and economic impact are often emphasized. Thus, global health is about worldwide health improvement, reduction of disparities, and protection against global threats that disregard national borders, including the most common causes of human death and years of life lost from a global perspective.

<span class="mw-page-title-main">Epidemiology of HIV/AIDS</span> Pandemic of HIV/AIDS

The global pandemic of HIV/AIDS began in 1981, and is an ongoing worldwide public health issue. According to the World Health Organization (WHO), by 2023, HIV/AIDS had killed approximately 40.4 million people, and approximately 39 million people were infected with HIV globally. Of these, 29.8 million people (75%) are receiving antiretroviral treatment. There were about 630,000 deaths from HIV/AIDS in 2022. The 2015 Global Burden of Disease Study estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year. Incidence of HIV has continued to fall, decreasing by 23% from 2010 to 2020, with progress dominated by decreases in Eastern Africa and Southern Africa. As of 2023, there are about 1.3 million new infections of HIV per year globally.

<span class="mw-page-title-main">HIV/AIDS in India</span>

HIV/AIDS in India is an epidemic. The National AIDS Control Organisation (NACO) estimated that 3.14 million people lived with HIV/AIDS in India in 2023. Despite being home to the world's third-largest population of persons with HIV/AIDS, the AIDS prevalence rate in India is lower than that of many other countries. In 2016, India's AIDS prevalence rate stood at approximately 0.30%—the 80th highest in the world. Treatment of HIV/AIDS is via a combination of antiretroviral drugs and education programs to help people avoid infection.

Beatrice Were is a Ugandan AIDS activist.

<span class="mw-page-title-main">HIV/AIDS in Zimbabwe</span> Major public health issue

HIV and AIDS is a major public health issue in Zimbabwe. The country is reported to hold one of the largest recorded numbers of cases in Sub-Saharan Africa. According to reports, the virus has been present in the country since roughly 40 years ago. However, evidence suggests that the spread of the virus may have occurred earlier. In recent years, the government has agreed to take action and implement treatment target strategies in order to address the prevalence of cases in the epidemic. Notable progress has been made as increasingly more individuals are being made aware of their HIV/AIDS status, receiving treatment, and reporting high rates of viral suppression. As a result of this, country progress reports show that the epidemic is on the decline and is beginning to reach a plateau. International organizations and the national government have connected this impact to the result of increased condom usage in the population, a reduced number of sexual partners, as well as an increased knowledge and support system through successful implementation of treatment strategies by the government. Vulnerable populations disproportionately impacted by HIV/AIDS in Zimbabwe include women and children, sex workers, and the LGBTQ+ population.

UNAIDS has said that HIV/AIDS in Indonesia is one of Asia's fastest growing epidemics. In 2010, it is expected that 5 million Indonesians will have HIV/AIDS. In 2007, Indonesia was ranked 99th in the world by prevalence rate, but because of low understanding of the symptoms of the disease and high social stigma attached to it, only 5-10% of HIV/AIDS sufferers actually get diagnosed and treated. According to the a census conducted in 2019, it is counted that 640,443 people in the country are living with HIV. The adult prevalence for HIV/ AIDS in the country is 0.4%. Indonesia is the country in Southeast Asia to have the most number of recorded people living with HIV while Thailand has the highest adult prevalence.

<span class="mw-page-title-main">HIV/AIDS in Canada</span>

HIV/AIDS was first detected in Canada in 1982. In 2018, there were approximately 62,050 people living with HIV/AIDS in Canada. It was estimated that 8,300 people were living with undiagnosed HIV in 2018. Mortality has decreased due to medical advances against HIV/AIDS, especially highly active antiretroviral therapy (HAART).

<span class="mw-page-title-main">Babatunde Osotimehin</span>

Babatunde Osotimehin was a Nigerian physician, who served as Minister of Health, and in 2011 became the executive director of the United Nations Population Fund, holding the rank of Under-Secretary-General of the United Nations, reappointed in August 2014 until his death. Osotimehin's interests were youth and gender, and he advocated for reproductive health and reproductive rights, particularly within the context of the HIV epidemic. One of his strengths was his reliance on data and evidence.

HIV prevention refers to practices that aim to prevent the spread of the human immunodeficiency virus (HIV). HIV prevention practices may be undertaken by individuals to protect their own health and the health of those in their community, or may be instituted by governments and community-based organizations as public health policies.

The XVIII International AIDS Conference was held in Vienna, Austria from July 18–23, 2010.

Julio S. G. Montaner, is an Argentine-born Canadian physician, professor and researcher. He is the director of the British Columbia Centre for Excellence in HIV/AIDS, the chair in AIDS Research and head of the Division of AIDS in the Faculty of Medicine at the University of British Columbia and the past-president of the International AIDS Society. He is also the director of the John Ruedy Immunodeficiency Clinic, and the Physician Program Director for HIV/AIDS PHC. He is known for his work on HAART, a role in the discovery of triple therapy as an effective treatment for HIV in the late 1990s, and a role in advocating the "Treatment as Prevention" Strategy in the mid-2000s, led by Myron Cohen of the HPTN 052 trial.

<span class="mw-page-title-main">Salim Abdool Karim</span> South African medical researcher

Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.

<span class="mw-page-title-main">Volodymyr Zhovtyak</span>

Volodymyr Zhovtyak is a Ukrainian social activist and a human rights defender. He is one of the leaders of the movement of people living with HIV/AIDS in Ukraine, and in the region of Eastern Europe and Central Asia. He is one of the founders of the national and international non-governmental organizations of PLWH, which collaborates with institutions of the United Nations, the European Union and the USA, as well as with the Cabinet of Ministers and the Presidential Administration of Ukraine.

INPUD is an international non-profit organization grouping local groups and collectives of people who use illicit drugs, which aims at "A world where people who use drugs are free to live their lives with dignity." INPUD was founded in 2006 in Vancouver, Canada, and formally launched in Copenhagen, Denmark, on 1 November 2008.

Robert S. Hogg is an HIV researcher focused on improving outcomes for people living with HIV/AIDS through the understanding of barriers to accessing HIV testing, treatment and care in Canada and globally. He is a senior research scientist and the former Director of the HIV/AIDS Drug Treatment Program at the B.C. Centre for Excellence in HIV/AIDS. He is a Simon Fraser University Distinguished Professor and the Associate Dean of Research of the faculty of Health Sciences. He is a prolific and highly cited author with an H-index of 111 and over 1000 peer-reviewed papers. He is both a Member of the Order of Canada and a Fellow of the Canadian Academy of Health Sciences.

Shannon Hader is an American public health physician who is the Dean of the School of International Service at American University. She is a published scientist and doctor, primarily focused on the HIV and AIDS epidemic. Her research specializes in infectious diseases.

References

  1. 1 2 3 4 "History of the International AIDS Conference" (PDF). AIDS2014. Retrieved 5 February 2019.
  2. Global Commission on Drug Policy. The War on Drugs and HIV/AIDS: How the Criminalization of Drug Use Fuels the Global Pandemic. Geneva, Switzerland: Global Commission on Drug Policy, 2012. Web. 5 February 2019.
  3. 1 2 3 "XVIII International AIDS Conference (AIDS 2010)". World Health Organization. Archived from the original on October 22, 2014. Retrieved 5 February 2019.
  4. Montaner, Michaela (October 2010). "The Vienna declaration: a call for drug policy reform". HIV/AIDS Policy & Law Review. 15 (1): 36–7. PMID   21413619.
  5. "HIV in people who use drugs". The Lancet. 376. July 20, 2010.
  6. Beyrer, Chris (16 May 2011). "The Golden Crescent and HIV/AIDS in Central Asia: Deadly Interactions". Global Public Health. 6 (5): 570–576. doi:10.1080/17441692.2011.572080. PMID   21590558. S2CID   40166984.
  7. "United Nations Millennium Development Goals." United Nations, United Nations, Sept. 2000,
  8. "Declaration of Commitment on HIV/AIDS (2001)" (PDF). UNAIDS. Retrieved 5 February 2019.
  9. "Political Declaration on HIV and AIDS (2006), universal access process, and civil society engagement" (PDF). UNAIDS. 2006.
  10. 1 2 3 4 5 Wood, Evan; Werb, Dan; Kerr, Thomas; Kazatchkine, Michel; Hankins, Catherine; Gorna, Gorna; Nutt, David; Des Jarlais, Don; Barre-Sinoussi, Francoise (July 20, 2010). "Vienna Declaration: a call for evidence-based drug policies". The Lancet. 376 (9738): 310–312. doi:10.1016/S0140-6736(10)60958-0. PMID   20650517. S2CID   43013609.
  11. Reuter, Peter (17 March 2009). "Ten years after the United Nationals General Assembly Special Session (UNGASS): assessing drug problems, policies and reform proposals". Addiction. 104 (4): 510–517. doi:10.1111/j.1360-0443.2009.02536.x. PMID   19335650.
  12. Degenhardt, Louisa (1 July 2008). "Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Finding from the WHO World Mental Health Surveys". PLOS Medicine. 5 (7): e141. doi: 10.1371/journal.pmed.0050141 . PMC   2443200 . PMID   18597549.
  13. 1 2 United Nations Commission on Narcotic Drugs and Commission on Crime Prevention and Criminal Justice, Organized Crime and its Threat to Security: Tackling a disturbing consequence of drug control (Vienna: United Nations, 2009).
  14. Wood, Evan; Marshall, Brandon DL; Montaner, Julio SG; Kerr, Thomas (March 11, 2009). "The war on drugs: a devastating public-policy disaster". The Lancet. 373 (9668): 989–990. doi:10.1016/S0140-6736(09)60455-4. PMID   19282025. S2CID   29467117.